Catalyst Wire Dossier Catalyst Wire Dossier

Intraocular anti-VEGF therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intraocular anti-VEGF therapy, covering 2016-04-04 to 2016-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Phase 4]

See pricing